Skip to main content
Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
4.110
+0.210 (5.38%)
At close: Mar 9, 2026, 4:00 PM EDT
3.990
-0.120 (-2.92%)
After-hours: Mar 9, 2026, 4:59 PM EDT

Voyager Therapeutics Revenue

In the year 2025, Voyager Therapeutics had annual revenue of $40.37M, down -49.53%. Voyager Therapeutics had revenue of $15.34M in the quarter ending December 31, 2025, with 144.28% growth.

Revenue (ttm)
$40.37M
Revenue Growth
-49.53%
P/S Ratio
5.66
Revenue / Employee
$234,733
Employees
172
Market Cap
228.52M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202540.37M-39.63M-49.53%
Dec 31, 202480.00M-170.01M-68.00%
Dec 31, 2023250.01M209.10M511.16%
Dec 31, 202240.91M3.49M9.33%
Dec 31, 202137.42M-133.71M-78.14%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Protalix BioTherapeutics 61.84M
Editas Medicine 40.52M
Sol-Gel Technologies 18.97M
MediWound 16.96M
Cartesian Therapeutics 2.80M
Humacyte 1.57M
Revenue Rankings

VYGR News

More News